Contribution of charged amino acids in the CDR2 region of CD4 to HIV-1 gp120 binding
- PMID: 1732513
Contribution of charged amino acids in the CDR2 region of CD4 to HIV-1 gp120 binding
Abstract
Several negatively charged amino acids of the human immunodeficiency virus type 1 (HIV-1) gp120 glycoprotein have been implicated in binding to the CD4 viral receptor. The CD4 region implicated in binding gp120 consists of a hydrophobic ridge protruding from a positively charged surface. To examine whether any of the surface charges on CD4 might contribute to gp120 binding, several amino acids near the CD4 regions previously implicated in gp120 binding were altered. Of the charged amino acids in the C'' and D strands of the amino-terminal domain of CD4, alteration of only two, lysine 46 and arginine 59, dramatically disrupted ability to bind gp120. In the three-dimensional structure of CD4, these two basic amino acids are located proximal to phenylalanine 43, which we confirmed to be important for gp120 binding. By contrast, we could not confirm the observations that alteration of residues in the F strand (CDR3-like region) of CD4 significantly affected gp120-binding ability. These results support a model of the gp120-binding site that is dependent on discontinuous amino acids but spatially limited.
Similar articles
-
The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure.J Exp Med. 1992 Aug 1;176(2):507-17. doi: 10.1084/jem.176.2.507. J Exp Med. 1992. PMID: 1500858 Free PMC article.
-
Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis.Proc Natl Acad Sci U S A. 1990 Sep;87(18):7150-4. doi: 10.1073/pnas.87.18.7150. Proc Natl Acad Sci U S A. 1990. PMID: 2402498 Free PMC article.
-
A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion.J Biol Chem. 1991 Mar 25;266(9):5942-8. J Biol Chem. 1991. PMID: 1706342
-
Characterization of a discontinuous epitope of the HIV envelope protein gp120 recognized by a human monoclonal antibody using chemical modification and mass spectrometric analysis.J Am Soc Mass Spectrom. 2010 Oct;21(10):1687-98. doi: 10.1016/j.jasms.2010.03.031. Epub 2010 Mar 31. J Am Soc Mass Spectrom. 2010. PMID: 20434359 Free PMC article.
-
Structure and interactions of CD4.Cold Spring Harb Symp Quant Biol. 1992;57:541-8. doi: 10.1101/sqb.1992.057.01.059. Cold Spring Harb Symp Quant Biol. 1992. PMID: 1339691 Review. No abstract available.
Cited by
-
A monoclonal antibody to the CDR-3 region of CD4 inhibits soluble CD4 binding to virions of human immunodeficiency virus type 1.J Virol. 1993 Jun;67(6):3656-9. doi: 10.1128/JVI.67.6.3656-3659.1993. J Virol. 1993. PMID: 8497074 Free PMC article.
-
Adaptation of human immunodeficiency virus type 1 to cells expressing a binding-deficient CD4 mutant (lysine 46 to aspartic acid).J Virol. 1995 May;69(5):2801-10. doi: 10.1128/JVI.69.5.2801-2810.1995. J Virol. 1995. PMID: 7707502 Free PMC article.
-
Identification of a contiguous 6-residue determinant in the MHV receptor that controls the level of virion binding to cells.Virology. 1997 Mar 17;229(2):336-48. doi: 10.1006/viro.1997.8446. Virology. 1997. PMID: 9126247 Free PMC article.
-
Determinants of human immunodeficiency virus type 1 entry in the CDR2 loop of the CD4 glycoprotein.J Virol. 1995 Jan;69(1):166-71. doi: 10.1128/JVI.69.1.166-171.1995. J Virol. 1995. PMID: 7983707 Free PMC article.
-
The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure.J Exp Med. 1992 Aug 1;176(2):507-17. doi: 10.1084/jem.176.2.507. J Exp Med. 1992. PMID: 1500858 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials